multi-valent vaccine

Real estate Ritz-Carlton to return to Seoul, tapped by IGIS Asset for landmark project

IGIS Asset Management Co., South Korea’s leading real estate investment firm, has named The Ritz-Carlton the preferred hotel brand for its amb...

Shipping & Shipbuilding HD KSOE wins $2.6 bn order for 12 container ships

South Korea’s largest shipbuilder HD Korea Shipbuilding & Offshore Engineering Co. (HD KSOE) said on Thursday it got 3.716 trillion won ...

Beauty & Cosmetics Amorepacific's Aestura to enter US market with Sephora

South Korean beauty and cosmetics giant Amorepacific Corp. said on Wednesday that its derma cosmetic brand Aestura will enter the American market wi...

Bio & Pharma SK Bioscience, Sanofi to develop next-gen pneumococcal vaccines

South Korea's SK Bioscience Co. said on Friday it signed an expanded agreement with Sanofi to co-develop next-generation pneumococcal conjugate vacc...

Chemical Industry LG Chem strengthens automotive adhesives biz

South Korea's LG Chem Ltd., the world’s fourth-largest chemical manufacturer, said on Wednesday it will expand into the automotive adhesives m...

Bio & Pharma SK Bioscience's SKYCellflu approved in Indonesia

SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, said on Wednesday that The Indonesian Food and Drug Authority BPOM ...

Artificial intelligence SK Telecom launches PC version of A Dot

South Korea's SK Telecom Co. unveiled the multi-large language model (LLM) agent, the PC version of its AI personal assistant service "A. (A Dot)" o...

Future mobility Hyundai Motor, Waymo forge multi-year, strategic partnership

South Korea’s top automaker Hyundai Motor Co. said on Friday it has entered into a multi-year strategic partnership with Waymo LLC to jointly ...

Korean startups Enormous market ahead for Hopae, S.Korean DID pioneer

To Hopae Inc., a digital identity solution-developing startup native to South Korea, its home market is small. After successfully accommodating more...

Bio & Pharma SK Bioscience sells stake in US vaccine developer Novavax

SK Bioscience Co., a drug-making arm of South Korea's No. 2 conglomerate SK Group, has sold a stake in Nasdaq-listed vaccine developer Novavax Inc. ...

Electric vehicles Humax, HeyCharge collaborate on EV charger

South Korea's mobility solutions company Humax Co. announced on Monday that it partnered with the Germany-based electric vehicle (EV) charging techn...

Batteries LG Energy signs multi-billion-dollar LFP battery deal with Renault

LG Energy Solution Ltd., the world’s second-largest battery maker, has clinched a multi-billion-dollar deal to supply LFP batteries for low-en...

Mergers & Acquisitions SK Bioscience to buy German vaccine maker IDT Biologika for $244 mn

South Korea’s vaccine developer SK Bioscience Co. will acquire a controlling stake in the world’s top 10 vaccine firm IDT Biologika GmbH...

Artificial intelligence Korea’s KT, Microsoft form strategic alliance on AI, cloud sectors

South Korea’s leading telecommunications service provider KT Corp. has formed a strategic alliance with US tech giant Microsoft Corp. to colla...

Energy Doosan Enerbility to supply SMR parts to NuScale Power

Doosan Enerbility Co., a leading South Korean power plant engineering company, is slated to supply nuclear reactor equipment to Nuscale Power Corp.,...

Bio & Pharma EuBiologics gets WHO certification for cholera vaccine facility

South Korea's EuBiologics Co. announced on Friday that the vaccine bulk production facility at its Chuncheon Plant No. 2 for the oral cholera vacc...

The KED View K-pop: Pros and cons of HYBE's multi-label system

Disputes between HYBE Co. and its label behind popular girl group NewJeans has made headlines as an almost unheard-of conflict in the K-pop industry...

Electronics Samsung wins multi-year built-in kitchen suite orders from Clayton

Samsung Electronics Co. is upping the ante to widen the lead in the US home appliance market with a long-term contract to provide its hyper-connecte...

Bio & Pharma SK Bioscience exports Sky Cellflu to Thailand

South Korea's SK Bioscience Co. announced on Thursday that it has shipped about 440,000 doses (for single-dose administration) of its cell-cultured ...

Beauty & Cosmetics Sephora to exit S.Korean market in May

Sephora, the world's leading multi-brand beauty retailer and an affiliate of French luxury conglomerate LVMH, announced on Tuesday that it will exit...

Artificial intelligence Samsung Electronics to hire big for AI R&D careers

Samsung Electronics Co. is ramping up its recruitment of experienced professionals across its Device eXperience (DX) and Device Solution (DS) divisi...

Cloud computing Naver Cloud, NHN Cloud to co-work for hyperscale AI

South Korea's Naver Cloud, the cloud computing unit of Naver Corp., and NHN Cloud Corp., announced on Monday that they have signed a memorandum of u...

Korean innovators at CES 2024 Samsung to unveil new Odyssey gaming monitors at CES

Samsung Electronics Co. announced on Wednesday that it will unveil new Odyssey OLED gaming monitors at CES 2024, the world's largest IT and consum...

Bio & Pharma SK Bioscience start to deliver Novavax COVID-19 vaccine

South Korea's SK Bioscience Co. announced on Tuesday that it started to deliver the Novavax COVID-19 vaccine against XBB.1.5 variant.According to No...

Bio & Pharma SK Bioscience applies Phase 3 trials in US for pneumococcal vaccine

South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...

Bio & Pharma Celltrion, Cyron to develop multi-specific antibody new drug

South Korea’s biopharmaceutical company Celltrion Inc. announced on Wednesday that it signed a joint research agreement with domestic startup ...

Bio & Pharma JW Holdings starts to export Winuf to Mongolia

South Korea's JW Holdings corporation announced on Tuesday that it started to export the multi-nutritional liquid Winuf Central 736·1085ml to...

Bio & Pharma Korea to invest $200 mn in new drugs, vaccines by 2028

South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...

Bio & Pharma GC Biopharma wins $10 mn order for flu vaccine in Thailand

South Korea's GC Biopharma Corp. announced on Thursday that its flu vaccine GC Flu secured a $10 million order in the upcoming bid by Thailand's Gov...

Bio & Pharma KAIST, IVI to collaborate on global vaccine research

The Korea Advanced Institute of Science & Technology (KAIST) announced on Thursday that it signed a memorandum of understanding (MOU) with the I...